Android/iOS App Development Competition Empowers Students with Real-World Mobile Tech Skills

Published on: April 7, 2025

The Himalayan School of Science & Technology organized an Android/iOS App Development Competition on 7th April 2025, aimed at providing students with practical experience in mobile application development for both Android and iOS platforms. This competition introduced participants to key development tools, frameworks, and industry best practices, emphasizing UI/UX design to create engaging and user-friendly applications.

Through hands-on project work, students learned to design intuitive interfaces, integrate essential functionalities, and deploy fully functional apps. The event encouraged innovation, problem-solving, and critical thinking while promoting effective teamwork and communication skills among participants.

With 68 students taking part, the competition served as a comprehensive learning platform that prepared them for real-world challenges in the mobile technology industry. Participants built a portfolio of mobile applications showcasing their skills and gained confidence in their ability to deliver industry-relevant projects.

Overall, the competition successfully enhanced students’ technical expertise, creativity, and collaboration, equipping them with a solid foundation for future careers in mobile app development.

Admissions Form

Admission Open For 2025

×

International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.